CELLARIA
Cellaria creates high-quality, next-generation in vitro disease models that reflect the unique nature of a patient’s biology. All of our models begin with tissue from a patient, capturing clinically relevant details that inform model characterization.
CELLARIA
Industry:
Biopharma Biotechnology Health Care
Founded:
2013-01-01
Address:
Wakefield, Massachusetts, United States
Country:
United States
Website Url:
http://www.cellariainc.com
Total Employee:
1+
Status:
Active
Contact:
+1 978 720 8051
Email Addresses:
[email protected]
Total Funding:
150 K USD
Technology used in webpage:
IPv6 Google Apps For Business Google Google Cloud Product Schema Hubspot HubSpot CMS Hub AddThis Microdata For Google Shopping Accelerated Mobile Pages
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
The Clinical Development of Carfilzomib
Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients .
Current Employees Featured
Founder
Official Site Inspections
http://www.cellariainc.com
- Host name: 178.103.198.104.bc.googleusercontent.com
- IP address: 104.198.103.178
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
